Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2012
10/04/2012US20120252697 Transformed human pluripotent stem cells and associated methods
10/04/2012US20120252123 Nucleic acid silencing sequences
10/04/2012US20120252122 Methods and compositions for increasing production of induced pluripotent stem cells (ipscs)
10/04/2012US20120252121 Culture Method for Amplifying Large Numbers of Hair Follicle Stem Cells in Vitro
10/04/2012US20120252120 Diazonium salt modification of silk polymer
10/04/2012US20120252119 Methods for the collection and maturation of oocytes
10/04/2012US20120252118 Plastic pressure vessel for biopharmaceutical applications and methods thereof
10/04/2012US20120252117 Optimized messenger rna
10/04/2012US20120252116 Fluid Flow Device Containing Nanotubes and Method for Cell Trafficking Using Same
10/04/2012US20120252114 Use of triplex structure dna in transferring nucleotide sequences
10/04/2012US20120252113 Use of triplex structure dna in transferring nucleotide sequences
10/04/2012US20120252099 Immunogenic minicells and methods of use
10/04/2012US20120252097 Therapeutic Agents Comprising Pro-Apoptotic Proteins
10/04/2012US20120252094 Recombinant Butyrylcholinesterases and Truncates Thereof
10/04/2012US20120252092 Clostridium histolyticum recombinant collagenases and method for the manufacture thereof
10/04/2012US20120252060 Self-Renewing Single Human Hematopoietic Stem Cells, an Early Lymphoid Progenitor and Methods of Enriching the Same
10/04/2012US20120252051 Tlr8 transgenic animals
10/04/2012US20120252028 Target genes for cancer therapy
10/04/2012US20120252023 Materials and Methods Useful for Affecting Tumor Cell Growth, Migration and Invasion
10/04/2012US20120252000 Real time multipoint assay for optimizing performance
10/04/2012US20120251999 Vitrification systems and methods
10/04/2012US20120251630 Remission therapy of cancer with isoflavonoids
10/04/2012US20120251620 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
10/04/2012US20120251616 Tocopherols, Tocotrienols, Other Chroman and Side Chain Derivatives and Uses Thereof
10/04/2012US20120251608 Cationic polymers for antimicrobial applications and delivery of bioactive materials
10/04/2012US20120251579 Compositions for generating an antigen specific immune response
10/04/2012US20120251571 Rnase l-mediated cleavage products and uses thereof
10/04/2012US20120251569 Composition for treating hbv infection
10/04/2012US20120251561 Administration of dendritic cells partially matured in vitro for the treatment of tumors
10/04/2012US20120251555 Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof
10/04/2012US20120251554 Anti-cd33 antibodies and use thereof for immunotargeting in treating cd33-associated illnesses
10/04/2012US20120251549 Complement inhibitors and uses thereof
10/04/2012US20120251543 Methods and compositions for modulating apoptosis
10/04/2012US20120251541 Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation
10/04/2012US20120251533 Monoclonal antibodies against cd30 lacking in fucosyl residues
10/04/2012US20120251532 Anti-alpha v beta 6 antibodies
10/04/2012US20120251529 Anti-cea antibodies
10/04/2012US20120251520 Ace2 activation for treatment of heart, lung and kidney disease and hypertension
10/04/2012US20120251514 Modulated programmed death ligand-1
10/04/2012US20120251513 Antigen Specific Tolerogenic Antigen Presenting Cells and Related Uses Compositions, Methods and Systems
10/04/2012US20120251510 Agents for promoting tissue regeneration by recruiting bone marrow mesenchymal stem cells and/or pluripotent stem cells into blood
10/04/2012US20120251509 Cell-based anti-cancer compositions and methods of making and using the same
10/04/2012US20120251506 Methods and compositions relating to neuronal cell and tissue differentiation
10/04/2012US20120251505 HUMAN LYMPHOID TISSUE INDUCER (LTi) CELL COMPOSITIONS AND METHODS OF USE
10/04/2012US20120251504 Pluripotent stem cells obtained from dental pulp
10/04/2012US20120251489 Adult stem cell derived conditioned medium and/or adult stem cells for use in the therapeutic treatment of a tumor disease
10/04/2012US20120251450 Nanoparticles that preferentially associate with and kill diseased cells for diagnostic and therapeutic applications
10/04/2012US20120251445 Peptides whose uptake by cells is controllable
10/04/2012DE102011001623A1 Preparing a preparation comprising human cells, comprises contacting hair follicles with aqueous buffer solution, separating buffer solution to obtain residue, washing residue and vibrating residue with enzyme free aqueous buffer solution
10/04/2012CA2831829A1 Genetic engineering methods and materials for enhancing plant yields
10/04/2012CA2831770A1 Retention of antigen-binding molecules in blood plasma and method for modifying immunogenicity
10/04/2012CA2831769A1 Membrane-separation-type culture device, membrane-separation-type culture kit, stem cell separation method using same, and separation membrane
10/04/2012CA2831609A1 Priming of pluripotent stem cells for neural differentiation
10/04/2012CA2831294A1 Compositions and methods to immunize against hepatitis c virus
10/04/2012CA2831284A1 Compositions and methods for inhibiting expression of tmprss6 gene
10/04/2012CA2831111A1 Cd37-binding molecules and immunoconjugates thereof
10/04/2012CA2831018A1 Method for using regulatory t cells in therapy
10/04/2012CA2830375A1 Methods and compositions for targeting adipose cells in mammals
10/04/2012CA2829804A1 Enriched populations of cardiomyocyte lineage cells from pluripotent stem cells
10/03/2012EP2505660A1 Method for screening of therapeutic agent for hyperlipemia
10/03/2012EP2505644A1 Atmosphere control composition
10/03/2012EP2505639A1 Method for manufacturing pancreatic-hormone-producing cells
10/03/2012EP2505638A1 Neuronal switching circuit
10/03/2012EP2505220A2 Method of proliferating human hepatocyte derived cells
10/03/2012EP2504432A2 Hydrogel-based vascular lineage cell growth media and uses thereof
10/03/2012EP2504426A1 Methods of preparing mesenchymal stem cells, compositions and kit thereof
10/03/2012EP2504425A1 Differentiation of human embryonic and induced pluripotents stem cells
10/03/2012EP2504424A1 Method for hepatic differentiation of definitive endoderm cells
10/03/2012EP2504423A1 Multi-purpose substrates useful for cell culture and methods for making and using the same
10/03/2012EP2503958A1 A method of inducing cellular growth and materials for use therewith
10/03/2012CN202465710U Kit convenient for isolated culture of granular cells
10/03/2012CN1993463B Follistatin mutant polypeptide
10/03/2012CN1890266B Antibodies
10/03/2012CN1867678B Neural colony forming assay
10/03/2012CN1646561B Gene conferring resistance to phytophthora infestans (late-blight) in solanacea
10/03/2012CN102713614A Germline stem cell banking system
10/03/2012CN102712923A Anti-iga1 antibody
10/03/2012CN102712921A Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereof
10/03/2012CN102712906A Novel method for producing differentiated cells
10/03/2012CN102712905A Methods for isolating mononuclear cells that include a subpopulation of mesenchymal progenitor cells and vascular cells that include a subpopulation of endothelial progenitor cells from umbilical cord tissue
10/03/2012CN102712904A Method for generation and regulation of iPS cells and compositions thereof
10/03/2012CN102712903A Generation of induced pluripotent stem cells from cord blood
10/03/2012CN102712902A Differentiation of human embryonic stem cells
10/03/2012CN102712901A Compositions for inducing differentiation into retinal cells from retinal progenitor cells or inducing proliferation of retinal cells comprising WNT signaling pathway activators
10/03/2012CN102712900A Method for differentiation into retinal cells from stem cells
10/03/2012CN102712899A Stem cell conditioned medium compositions
10/03/2012CN102712898A Method for preparing substrate for arraying animal cells thereon and method for preparing substrate having animal cells arrayed thereon
10/03/2012CN102712897A Cardiac tissue-derived cells
10/03/2012CN102712896A Mass propagation method for hair follicle stem cells
10/03/2012CN102712881A Novel mannanase variants
10/03/2012CN102712696A Coiled coil and/or tether containing protein complexes and uses thereof
10/03/2012CN102711815A Adjuvant for vaccines, vaccines that comprise said adjuvant and uses thereof
10/03/2012CN102711799A Compositions and methods for wound treatment
10/03/2012CN102711446A Plants expressing cell wall degrading enzymes and expression vectors
10/03/2012CN102703601A Multifunctional magnetic fluorescent microsphere and preparation method and application thereof
10/03/2012CN102703507A shRNA lentiviral expression vector for specifically inhibiting hepatic cell CYP2E1 gene expression, constructing method and application thereof
10/03/2012CN102703504A shRNA (short hairpin ribonucleic acid) transgene recombinant plasmid capable of inhibiting foot and mouth disease virus and application thereof
10/03/2012CN102703503A Human and mammal cell attachment expression vector and application thereof
10/03/2012CN102703498A Multi-gene plant expression vector and construction method as well as application thereof
10/03/2012CN102703476A New L-sorbose/L-sorbic ketone dehydrogenase gene and application thereof
1 ... 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 ... 1827